P394 Rate of and Response to Dose Escalation in Patients Treated with Adalimumab for Moderately to Severely Active Ulcerative Colitis: Subanalysis of ULTRA 2
Journal of Crohn's and colitis(2013)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined